Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Mais filtros










Intervalo de ano de publicação
1.
Artigo em Chinês | WPRIM (Pacífico Ocidental) | ID: wpr-940194

RESUMO

Ovarian cancer is a malignant tumor of female reproductive system with high morbidity and mortality. Currently, ovarian cancer patients are mainly treated by primary debulking surgery combined with taxotere/cyclophosphamide (TC) chemotherapy, with the five-year survival rate of 36%-46%. Chinese medicinal materials play a positive role in preventing the occurrence and development of ovarian cancer via multiple targets. The flavonoid monomers in representative Chinese herbal medicines, such as Epimedii Folium, Scutellariae Radix, Curcumae Longae Rhizoma, Ginkgo Folium, Bupleuri Radix, and Longicerae Japonicae Flos, have been proved to have significant anti-tumor activity and been widely used in the treatment of malignant tumors. We reviewed the relevant literature and summarized that flavonoid monomers can regulate multiple signaling pathways to inhibit cell proliferation, block tumor cell cycle, induce apoptosis and autophagy, reduce the ability of cell invasion and migration, inhibit tumor angiogenesis, and reverse platinum resistance, thereby inhibiting the occurrence and development of ovarian cancer. Such pathways include phosphatidylinositol 3- kinase (PI3K)/protein kinase B (Akt)/mammalian target of rapamycin (mTOR) signaling pathway, Janus kinase (JAK)/signal transducer and activator of transcription 3 (STAT3) signaling pathway, mitogen-activated protein kinase (MAPK) signaling pathway, secreted glycoprotein (Wnt)/β-catenin signaling pathway, Notch signaling pathway, and nuclear factor kappaB (NF-κB) signaling pathway. By reviewing the regulatory effect of flavonoid monomers on the signaling pathways of ovarian cancer, we aim to provide a theoretical basis for the research on the roles of flavonoid monomers in inhibiting the occurrence and development of ovarian cancer.

2.
Artigo em Chinês | WPRIM (Pacífico Ocidental) | ID: wpr-940162

RESUMO

Ovarian cancer is a malignant tumor of female reproductive system with high morbidity and mortality. Currently, ovarian cancer patients are mainly treated by primary debulking surgery combined with taxotere/cyclophosphamide (TC) chemotherapy, with the five-year survival rate of 36%-46%. Chinese medicinal materials play a positive role in preventing the occurrence and development of ovarian cancer via multiple targets. The flavonoid monomers in representative Chinese herbal medicines, such as Epimedii Folium, Scutellariae Radix, Curcumae Longae Rhizoma, Ginkgo Folium, Bupleuri Radix, and Longicerae Japonicae Flos, have been proved to have significant anti-tumor activity and been widely used in the treatment of malignant tumors. We reviewed the relevant literature and summarized that flavonoid monomers can regulate multiple signaling pathways to inhibit cell proliferation, block tumor cell cycle, induce apoptosis and autophagy, reduce the ability of cell invasion and migration, inhibit tumor angiogenesis, and reverse platinum resistance, thereby inhibiting the occurrence and development of ovarian cancer. Such pathways include phosphatidylinositol 3- kinase (PI3K)/protein kinase B (Akt)/mammalian target of rapamycin (mTOR) signaling pathway, Janus kinase (JAK)/signal transducer and activator of transcription 3 (STAT3) signaling pathway, mitogen-activated protein kinase (MAPK) signaling pathway, secreted glycoprotein (Wnt)/β-catenin signaling pathway, Notch signaling pathway, and nuclear factor kappaB (NF-κB) signaling pathway. By reviewing the regulatory effect of flavonoid monomers on the signaling pathways of ovarian cancer, we aim to provide a theoretical basis for the research on the roles of flavonoid monomers in inhibiting the occurrence and development of ovarian cancer.

3.
Preprint em Inglês | medRxiv | ID: ppmedrxiv-20081059

RESUMO

BackgroundEffective therapies are urgently needed for the SARS-CoV-2 pandemic. Chloroquine has been proved to have antiviral effect against coronavirus in vitro. In this study, we aimed to assess the efficacy and safety of chloroquine with different doses in COVID-19. MethodIn this multicenter prospective observational study, we enrolled patients older than 18 years old with confirmed SARS-CoV-2 infection excluding critical cases from 12 hospitals in Guangdong and Hubei Provinces. Eligible patients received chloroquine phosphate 500mg, orally, once (half dose) or twice (full dose) daily. Patients treated with non-chloroquine therapy were included as historical controls. The primary endpoint is the time to undetectable viral RNA. Secondary outcomes include the proportion of patients with undetectable viral RNA by day 10 and 14, hospitalization time, duration of fever, and adverse events. ResultsA total of 197 patients completed chloroquine treatment, and 176 patients were included as historical controls. The median time to achieve an undetectable viral RNA was shorter in chloroquine than in non-chloroquine (absolute difference in medians -6.0 days; 95% CI -6.0 to -4.0). The duration of fever is shorter in chloroquine (geometric mean ratio 0.6; 95% CI 0.5 to 0.8). No serious adverse events were observed in the chloroquine group. Patients treated with half dose experienced lower rate of adverse events than with full dose. ConclusionsAlthough randomised trials are needed for further evaluation, this study provides evidence for safety and efficacy of chloroquine in COVID-19 and suggests that chloroquine can be a cost-effective therapy for combating 102 the COVID-19 pandemic.

4.
Clinical Medicine of China ; (12): 476-480, 2012.
Artigo em Chinês | WPRIM (Pacífico Ocidental) | ID: wpr-418814

RESUMO

Objective To investigate the relationship between atherosclerosis and cardiovascular risk factors in the elderly,thus to provide new method for detection of atherosclerosis in the elderly.Methods From November 2010 to October 2011,348 elderly who addmitted to or had physical examination in our hospital were recruited in the study.All participants were interviewed through questionnaire,and medical history was recorded,Brachial-ankle pulse wave velocity (baPWV) was measured.Simultaneously,height,body weight,waist circumferrence,triglyceride ( TG ),total cholesterol ( TC ),high density lipoprotein-cholesterol ( HDL-C ),low density lipoprotein-cholesterol(LDL-C) were measured.The association between baPWV and cardiovascular and atherosclerosis was investigated.Results The incidence of higher baPWV was increasing as the number of risk factors of cardio vascular disease adding.Logistic regression analysis show that:Age ( OR =5.223,95% CI 3.606 -7.564),LDL-C( OR =4.554,95% CI 2.413 - 8.593 ),Smoking ( OR =6.007,95% CI 3.775 - 9.560),Obesity( OR =3.019,95 % CI 2.363 - 3.857 ),Hypertension ( OR =6.938,95% CI 3.591 - 13.404 ),High-salt diet( OR =2.555,95% CI 2.108 -3.096)were independent risk factors of baPWV increase (P <0.05); Exercise and good sleep were the protective factors for baPWV increasing.BaPWV levels were significantly lower in the exercise group (exercise time > 1 h/d)than in the few exercise group (exercise time < 1h/d) (t =2.719,P =0.012 ),and lower in good sleep group participants than in insomnia participants (t =2.561,P =0.017 ) (P < 0.05 ).BaPWV levels were significantly higherin the group with essential hypertension ( 1852.0 ± 46.7 cm/s),with Type 2 Diabetes Mellitus ( 1693.0 ± 38.2 cm/s),with coronary heart disease ( 1729.0 ± 40.4 cm/s) than in the healthy group ( 1356.0 ± 3 1.3 cm/s) ( P < 0.05 ).There was no statistical difference between the essential hypertension group and the hypertension complicated with cerebral infarction group,as well as between the coronary heart disease group and the myocardial infarction group.Conclusion Age,LDL-C increasing,smoking,obesity,hypertension and high-salt diet were independent risk factors of baPWV increase;Exercise and good sleep were protective factors.BaPWV could be one of the methods for early detection of atherosclerosis.

5.
Artigo em Chinês | WPRIM (Pacífico Ocidental) | ID: wpr-959103

RESUMO

@#Objective To investigate the mental health and related factors for benign prostatic hyperplasia (BPH) patients. Methods 200 patients with BPH were investigate with the 4 dimensions of Quality of Life Scale for BPH patients (BPHQLS): worry about disease, psychological mood, social interaction and satisfaction. Results 85.50% of patients with BPH were in medium or poor mental health (standard score ≤80%). The total score of BPHQLS did not correlate with age, course of disease, and marital status (P>0.05), but correlated with degree of education and profession (P<0.05). Partial correlation analysis showed the total score correlated with the years of education (P<0.01). Conclusion Patients with BPH are in poor mental health. Degree of education is the main factors related with their mental health.

SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...